Evaluating an Ebola and a Marburg Vaccine in Uganda
- Conditions
- Ebola Virus DiseaseMarburg Virus Disease
- Interventions
- Biological: Ebola vaccineBiological: Marburg vaccineOther: Placebo injection
- First Posted Date
- 2009-10-19
- Last Posted Date
- 2013-01-28
- Target Recruit Count
- 108
- Registration Number
- NCT00997607
- Locations
- 🇺🇬
Makerere University Walter Reed Project (MUWRP) clinic, Kampala, Uganda
VRC 309: A Multi-Center, Open-Label, Randomized Phase I Study of an Investigational Influenza DNA Vaccine Followed by 2009/2010 Seasonal Influenza Trivalent Inactivated Vaccine (TIV) Compared to Two Injections of TIV in Adults 45-70 Years
- Conditions
- Influenza, Human
- First Posted Date
- 2009-10-16
- Last Posted Date
- 2017-07-02
- Target Recruit Count
- 60
- Registration Number
- NCT00995982
- Locations
- 🇺🇸
National Institutes of Health Clinical Center, 9000 Rockville Pike, Bethesda, Maryland, United States
🇺🇸Clinical Alliance for Research and Education, Annandale, Virginia, United States
Novartis H1N1 Vaccine in Pregnant Women
- Conditions
- Influenza
- Interventions
- Biological: Inactivated H1N1 Vaccine
- First Posted Date
- 2009-10-09
- Last Posted Date
- 2013-08-07
- Target Recruit Count
- 84
- Registration Number
- NCT00992719
- Locations
- 🇺🇸
University of Maryland Baltimore, Baltimore, Maryland, United States
🇺🇸Baylor College of Medicine - Department of Molecular Virology and Microbiology, Houston, Texas, United States
🇺🇸Group Health Cooperative, Seattle, Washington, United States
H1N1 Vaccine at Two Dose Levels in HIV Positive Adults
- Conditions
- Influenza
- Interventions
- Biological: Inactivated Influenza H1N1 vaccine
- First Posted Date
- 2009-10-09
- Last Posted Date
- 2012-05-16
- Target Recruit Count
- 192
- Registration Number
- NCT00992433
- Locations
- 🇺🇸
Baylor College of Medicine, Houston, Texas, United States
🇺🇸University of Washington, Seattle, Washington, United States
🇺🇸University of Maryland Baltimore - Institute of Human Virology, Baltimore, Maryland, United States
Safety of and Immune Response to an H1N1 Influenza Virus Vaccine in HIV Infected Children and Youth
- Conditions
- HIV InfectionsH1N1 Influenza Virus
- Interventions
- Biological: Influenza A (H1N1) 2009 monovalent vaccine
- First Posted Date
- 2009-10-09
- Last Posted Date
- 2021-11-05
- Target Recruit Count
- 155
- Registration Number
- NCT00992836
- Locations
- 🇺🇸
Rush Univ. Cook County Hosp. Chicago NICHD CRS, Chicago, Illinois, United States
🇺🇸Ann & Robert H. Lurie Children's Hospital of Chicago (LCH) CRS, Chicago, Illinois, United States
🇺🇸Rutgers - New Jersey Medical School CRS, Newark, New Jersey, United States
Safety of and Immune Response to an H1N1 Influenza Vaccine in HIV Infected Pregnant Women
- Conditions
- HIV InfectionsH1N1 Influenza Virus
- Interventions
- Biological: Influenza A (H1N1) monovalent vaccine
- First Posted Date
- 2009-10-08
- Last Posted Date
- 2021-11-05
- Target Recruit Count
- 130
- Registration Number
- NCT00992017
- Locations
- 🇺🇸
University of California, UC San Diego CRS, La Jolla, California, United States
🇺🇸Usc La Nichd Crs, Alhambra, California, United States
🇺🇸Washington Hosp. Ctr. NICHD CRS, Washington, District of Columbia, United States
Nitazoxanide Plus Ribavirin and Peginterferon for Therapy of Treatment Naive HCV Genotype 1 and HIV Coinfected Subjects
- Conditions
- HIV InfectionHepatitis C Infection
- Interventions
- First Posted Date
- 2009-10-08
- Last Posted Date
- 2021-11-04
- Target Recruit Count
- 68
- Registration Number
- NCT00991289
- Locations
- 🇺🇸
Stanford AIDS Clinical Trials Unit CRS, Palo Alto, California, United States
🇺🇸Columbia P&S CRS, New York, New York, United States
🇺🇸Trillium Health ACTG CRS, Rochester, New York, United States
Safety, Tolerability, and Effect of TMC207 and Efavirenz in Healthy Volunteers
- First Posted Date
- 2009-10-08
- Last Posted Date
- 2021-11-01
- Target Recruit Count
- 37
- Registration Number
- NCT00992069
- Locations
- 🇺🇸
Unc Aids Crs, Chapel Hill, North Carolina, United States
🇺🇸Ucsf Aids Crs, San Francisco, California, United States
🇺🇸Johns Hopkins Adult AIDS CRS, Baltimore, Maryland, United States
Safety of and Immune Response to the PENNVAX-B DNA Vaccine With and Without IL-12 in HIV-uninfected Adults
- Conditions
- HIV Infections
- Interventions
- Biological: PENNVAX-BBiological: IL-12 DNA plasmids
- First Posted Date
- 2009-10-08
- Last Posted Date
- 2021-10-14
- Target Recruit Count
- 48
- Registration Number
- NCT00991354
- Locations
- 🇺🇸
Univ. of Rochester HVTN CRS, Rochester, New York, United States
🇺🇸3535 Market Street CRS, Philadelphia, Pennsylvania, United States
🇺🇸Vanderbilt Vaccine CRS, Nashville, Tennessee, United States
A Pilot Study for Collection of Anti-Influenza A Immune Plasma
- Conditions
- Influenza A Virus InfectionSwine Flu
- First Posted Date
- 2009-09-25
- Last Posted Date
- 2019-08-19
- Target Recruit Count
- 102
- Registration Number
- NCT00984451
- Locations
- 🇺🇸
AIDS Clinical Trials Unit, NYU School of Medicine, New York, New York, United States
🇺🇸Cornell Clinical Trials Unit, New York Presbyterian Hospital, Weill Cornell Medical College, New York, New York, United States
🇺🇸National Institutes of Health Clinical Center, 9000 Rockville Pike, Bethesda, Maryland, United States